Research programme: vaccines - Mariposa Health
Alternative Names: Golden staph vaccine - Hunter Immunology; H 003; H 003 plus adjuvant; MH 003Latest Information Update: 28 Jul 2019
At a glance
- Originator Hunter Immunology
- Developer Mariposa Health Limited
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Staphylococcal infections
- Discontinued Candidiasis; Pseudomonal infections
Most Recent Events
- 28 Jul 2019 No recent reports of development identified for preclinical development in Staphylococcal-infections(Prevention) in Australia (PO)
- 07 Jan 2016 Discontinued - Preclinical for Candidiasis in Australia (PO)
- 07 Jan 2016 Discontinued - Preclinical for Pseudomonal infections in Australia (PO)